EFB Dengue Literature Review

IRF4

5 min read

IRF4

Overview

IRF4 (Interferon Regulatory Factor 4) is a transcription factor essential for plasma cell differentiation. IRF4 and IRF8 reciprocally regulate each other to determine plasma cell vs. germinal centre fates: high IRF4 with low IRF8 drives PC differentiation, while the reverse promotes GC B cell identity. In DN2 cells, the IRF4/IRF8 ratio is shifted toward PC fate.

Key Points from Literature

  • High IRF4, low IRF8 in DN2 cells: IRF4 transcription is higher in SLE DN2 cells than SWM; IRF8 is lower in DN2 than any other B cell subset. The IRF4/IRF8 ratio is significantly lower (i.e., skewed toward IRF4) in aNAV and DN2 cells relative to other subsets in both HCD and SLE — consistent with promotion of a PC rather than memory fate (see Jenks2018 - DN2 B Cells and EF Pathway in SLE, RNA-seq + flow cytometry n=5 HCD + n=5 SLE).

  • IRF4 target gene enrichment: GSEA shows that DN2 cells transcribe higher amounts of IRF4 target genes expressed by PC, relative to SWM. Genes with binding motifs for IRF4 and its co-factor SPI1 (PU.1) are enriched in the DN2 transcriptome (see Jenks2018 - DN2 B Cells and EF Pathway in SLE).

  • Low ETS1 amplifies IRF4 effect: DN2 cells express low ETS1, a TF that represses PC differentiation. ETS1 deficiency leads to accumulation of extrafollicular autoreactive B cells (citing Russell et al. 2015). The combination of high IRF4 and low ETS1 in the absence of BACH2 creates a transcriptional environment strongly biased toward PC differentiation (see Jenks2018 - DN2 B Cells and EF Pathway in SLE).

  • IRF4 listed as entity in COVID-19 EF ASC context: Woodruff2020 identifies IRF4 among the transcription factors relevant to the EF-derived ASC programme in severe COVID-19, consistent with the IRF4-high/IRF8-low signature defined in SLE DN2 cells (see Woodruff2020 - EF B Cell Responses in COVID-19, n=17 COVID-19 prospective cohort).

  • IRF4 motifs enriched in ABC chromatin: In SWEF-deficient lupus mice, ABC chromatin shows enhanced accessibility in areas enriched for T-bet, AP-1, and IRF4 binding motifs — the same motifs enriched in human SLE DN2 cells. IRF4 is thus part of a conserved mouse-human ABC regulatory programme (see Sanz2025 - Human Atypical B Cells Overview, review).

  • IRF4 NOT upregulated in alternative lineage atBC clusters: scRNA-seq of >12,000 B cells showed that IRF4 was not upregulated in any atBC cluster (atBC1, atBC2, atBC3) or in MBC1 — only in PCs, which were detached from the alternative lineage pseudotime trajectory. This absence of IRF4 upregulation is one of three lines of evidence (alongside absent XBP1 and PRDM1) that alternative lineage cells are not pre-plasmablasts in healthy/infection contexts. The contrast with the high IRF4 in SLE DN2 cells (Jenks2018) underscores the context-dependence of PC programming (see Sutton2021 - Alternative Lineage B Cells in Vaccination and Infection, n=4, 10x Chromium).

  • Intermediate IRF4 marks the tripotent activated precursor — the pre-GC branch point. Activated B cells at the follicular perimeter acquire a surface phenotype coexpressing naive/memory markers (CD38, CCR6) and activated/GC markers (CD95, GL7), express intermediate levels of IRF4, and exhibit absent or low BCL6. IRF4 “is required for both PC and GC B cell differentiation,” so its intermediate level is characteristic of the uncommitted precursor rather than of either destination (see Glaros2025 - Multilayered Identity of B Cell Memory, review, no original data, mouse). This precursor is tripotent — a single naive B cell can give rise to early plasma cells, early memory B cells, and GC B cells.

  • ⚠ Note the unresolved tension the wiki already tracks. Sutton2021 - Alternative Lineage B Cells in Vaccination and Infection found IRF4 (with PRDM1 and XBP1) not upregulated in human atBC clusters, whereas Jenks2018 - DN2 B Cells and EF Pathway in SLE reports a high IRF4/low IRF8 ratio in DN2. Glaros2025 cites primaries reporting PC-associated gene expression in ABCs, and attributes the contrary functional literature partly to soluble-antigen stimulation artefact — see DN2 B Cell Contradictions.

  • IRF4 induction is IFN-γR-dependent but T-bet-independent. In mouse Be1 cultures, deleting Tbx21 did not alter early expression or activity of any canonical ASC transcription factor including Irf4; deleting Ifngr1 kept Irf4 low through day 4 alongside Prdm1, Pou2af1 and Xbp1, with no ASC formation (see Stone2019 - T-bet Promotes ASC Differentiation by Limiting IFN-gamma Inflammation, mouse, qPCR + RNA-seq + ATAC-seq). Stone’s framing places IRF4 with Blimp-1 as a genuine master regulator of ASC development, in explicit contrast to T-bet, which “is not.” Relevant to the PRDM1/XBP1/IRF4 trio that Sutton2021 - Alternative Lineage B Cells in Vaccination and Infection found un-upregulated in resting human atBCs — see BLIMP-1 Contradictions.

  • ★ IRF4 tracks the pre-ASC → ASC transition reciprocally with T-bet, and its motifs open before IL-21 arrives. The IFN-γ-induced pre-ASC is T-bet^hi^IRF4^int^, and the ASC it becomes is T-bet^lo^IRF4^hi^ — so IRF4 rises as T-bet falls across the final differentiation step. IRF4 upregulation was blocked by omitting IFN-γ along with T-bet. Critically, ATAC-seq at day 3 showed chromatin around IRF4 and BLIMP1 binding motifs already highly enriched in the IFN-γ+IL-2 condition — the ASC-commitment factors were remodelling the genome before IL-21 was ever added; IRF4 motifs were among those marking the 4 DARs at the PRDM1 locus (see Zumaquero2019 - IFN-gamma Programs T-bet-hi B Cells for ASC Differentiation, human, n=20 HD + n=40 SLE + in vitro reconstruction, ATAC-seq n=2/group).

Contradictions & Debates

None documented in current wiki sources.

BLIMP-1, DN2 B Cell, Plasmablast, BACH2, Extrafollicular Response, Early Memory B Cell, Extrafollicular Response, Germinal Center

Sources

Graph View

Backlinks